Rotavirus Reassortant–Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia

Background and Aims Biliary atresia (BA) is a devastating neonatal cholangiopathy that progresses to fibrosis and end‐stage liver disease by 2 years of age. Portoenterostomy may reestablish biliary drainage, but, despite drainage, virtually all afflicted patients develop fibrosis and progress to end...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology (Baltimore, Md.) Md.), 2020-04, Vol.71 (4), p.1316-1330
Hauptverfasser: Mohanty, Sujit K., Lobeck, Inna, Donnelly, Bryan, Dupree, Phylicia, Walther, Ashley, Mowery, Sarah, Coots, Abigail, Bondoc, Alexander, Sheridan, Rachel M., Poling, Holly M., Temple, Haley, McNeal, Monica, Sestak, Karol, Bansal, Ruchi, Tiao, Greg
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1330
container_issue 4
container_start_page 1316
container_title Hepatology (Baltimore, Md.)
container_volume 71
creator Mohanty, Sujit K.
Lobeck, Inna
Donnelly, Bryan
Dupree, Phylicia
Walther, Ashley
Mowery, Sarah
Coots, Abigail
Bondoc, Alexander
Sheridan, Rachel M.
Poling, Holly M.
Temple, Haley
McNeal, Monica
Sestak, Karol
Bansal, Ruchi
Tiao, Greg
description Background and Aims Biliary atresia (BA) is a devastating neonatal cholangiopathy that progresses to fibrosis and end‐stage liver disease by 2 years of age. Portoenterostomy may reestablish biliary drainage, but, despite drainage, virtually all afflicted patients develop fibrosis and progress to end‐stage liver disease requiring liver transplantation for survival. Approach and Results In the murine model of BA, rhesus rotavirus (RRV) infection of newborn pups results in a cholangiopathy paralleling human BA and has been used to study mechanistic aspects of the disease. Unfortunately, nearly all RRV‐infected pups succumb by day of life 14. Thus, in this study we generated an RRV‐TUCH rotavirus reassortant (designated as TR(VP2,VP4)) that when injected into newborn mice causes an obstructive jaundice phenotype with lower mortality rates. Of the mice that survived, 63% developed Ishak stage 3‐5 fibrosis with histopathological signs of inflammation/fibrosis and bile duct obstruction. Conclusions This model of rotavirus‐induced neonatal fibrosis will provide an opportunity to study disease pathogenesis and has potential to be used in preclinical studies with an objective to identify therapeutic targets that may alter the course of BA.
doi_str_mv 10.1002/hep.30907
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7384231</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2313358540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4437-5ca2358b1f090ac8eb1d79c124a41c2d4409e7d0f53cdc2304f4297b609204523</originalsourceid><addsrcrecordid>eNp1kc9O3DAQh62qVVmgh75AZamX9pBl_CckuSBtEbBIi4oQXLEcZwJG3nixk6248Q68IU-CtwuIIvU0h_n06TfzI-QrgzED4DvXuBgLqKD4QEYs50UmRA4fyQh4AVnFRLVBNmO8AYBK8vIz2RBMSi44H5HLM9_rpQ1DpGeoY_Sh113_eP9w3DWDwYaeDMF2SE98g476ls7sEgM9tHXw0UZ6qoN2Dl2k02GuO_rLOqvDHZ30AaPV2-RTq13EL89zi1wcHpzvT7PZ76Pj_cksM1KKIsuN5iIva9amK7QpsWZNURnGpZbM8EZKqLBooM2FaQwXIFvJq6LehYqDzLnYIntr72Ko59gY7PqUSy2Cnac0ymur_t109lpd-aUqRJk-wZLgx7Mg-NsBY6_mNhp0Tnfoh6hWTEqYS0jo93fojR9Cl85LVFlCyRmIRP1cUyY9KgZsX8MwUKvWVGpN_W0tsd_epn8lX2pKwM4a-GMd3v3fpKYHp2vlEwVVog4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2388082103</pqid></control><display><type>article</type><title>Rotavirus Reassortant–Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Mohanty, Sujit K. ; Lobeck, Inna ; Donnelly, Bryan ; Dupree, Phylicia ; Walther, Ashley ; Mowery, Sarah ; Coots, Abigail ; Bondoc, Alexander ; Sheridan, Rachel M. ; Poling, Holly M. ; Temple, Haley ; McNeal, Monica ; Sestak, Karol ; Bansal, Ruchi ; Tiao, Greg</creator><creatorcontrib>Mohanty, Sujit K. ; Lobeck, Inna ; Donnelly, Bryan ; Dupree, Phylicia ; Walther, Ashley ; Mowery, Sarah ; Coots, Abigail ; Bondoc, Alexander ; Sheridan, Rachel M. ; Poling, Holly M. ; Temple, Haley ; McNeal, Monica ; Sestak, Karol ; Bansal, Ruchi ; Tiao, Greg</creatorcontrib><description>Background and Aims Biliary atresia (BA) is a devastating neonatal cholangiopathy that progresses to fibrosis and end‐stage liver disease by 2 years of age. Portoenterostomy may reestablish biliary drainage, but, despite drainage, virtually all afflicted patients develop fibrosis and progress to end‐stage liver disease requiring liver transplantation for survival. Approach and Results In the murine model of BA, rhesus rotavirus (RRV) infection of newborn pups results in a cholangiopathy paralleling human BA and has been used to study mechanistic aspects of the disease. Unfortunately, nearly all RRV‐infected pups succumb by day of life 14. Thus, in this study we generated an RRV‐TUCH rotavirus reassortant (designated as TR(VP2,VP4)) that when injected into newborn mice causes an obstructive jaundice phenotype with lower mortality rates. Of the mice that survived, 63% developed Ishak stage 3‐5 fibrosis with histopathological signs of inflammation/fibrosis and bile duct obstruction. Conclusions This model of rotavirus‐induced neonatal fibrosis will provide an opportunity to study disease pathogenesis and has potential to be used in preclinical studies with an objective to identify therapeutic targets that may alter the course of BA.</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.30907</identifier><identifier>PMID: 31442322</identifier><language>eng</language><publisher>United States: Wolters Kluwer Health, Inc</publisher><subject>Animal models ; Animals ; Bile ; Bile ducts ; Biliary atresia ; Biliary Atresia - complications ; Cell Line ; Chlorocebus aethiops ; Disease Models, Animal ; Fibrosis ; Hepatology ; Humans ; Jaundice ; Jaundice, Obstructive - virology ; Juveniles ; Liver Cirrhosis - etiology ; Liver Cirrhosis - virology ; Liver diseases ; Liver transplantation ; Mice ; Mice, Inbred BALB C ; Neonates ; Original ; Phenotypes ; Reassortant Viruses ; Rotavirus ; Therapeutic applications ; Viruses ; Wound drainage</subject><ispartof>Hepatology (Baltimore, Md.), 2020-04, Vol.71 (4), p.1316-1330</ispartof><rights>2019 The Authors. H published by Wiley Periodicals, Inc. on behalf of American Association for the Study of Liver Diseases.</rights><rights>2019 The Authors. Hepatology published by Wiley Periodicals, Inc. on behalf of American Association for the Study of Liver Diseases.</rights><rights>2019. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4437-5ca2358b1f090ac8eb1d79c124a41c2d4409e7d0f53cdc2304f4297b609204523</citedby><cites>FETCH-LOGICAL-c4437-5ca2358b1f090ac8eb1d79c124a41c2d4409e7d0f53cdc2304f4297b609204523</cites><orcidid>0000-0002-8603-2876</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.30907$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.30907$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31442322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohanty, Sujit K.</creatorcontrib><creatorcontrib>Lobeck, Inna</creatorcontrib><creatorcontrib>Donnelly, Bryan</creatorcontrib><creatorcontrib>Dupree, Phylicia</creatorcontrib><creatorcontrib>Walther, Ashley</creatorcontrib><creatorcontrib>Mowery, Sarah</creatorcontrib><creatorcontrib>Coots, Abigail</creatorcontrib><creatorcontrib>Bondoc, Alexander</creatorcontrib><creatorcontrib>Sheridan, Rachel M.</creatorcontrib><creatorcontrib>Poling, Holly M.</creatorcontrib><creatorcontrib>Temple, Haley</creatorcontrib><creatorcontrib>McNeal, Monica</creatorcontrib><creatorcontrib>Sestak, Karol</creatorcontrib><creatorcontrib>Bansal, Ruchi</creatorcontrib><creatorcontrib>Tiao, Greg</creatorcontrib><title>Rotavirus Reassortant–Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>Background and Aims Biliary atresia (BA) is a devastating neonatal cholangiopathy that progresses to fibrosis and end‐stage liver disease by 2 years of age. Portoenterostomy may reestablish biliary drainage, but, despite drainage, virtually all afflicted patients develop fibrosis and progress to end‐stage liver disease requiring liver transplantation for survival. Approach and Results In the murine model of BA, rhesus rotavirus (RRV) infection of newborn pups results in a cholangiopathy paralleling human BA and has been used to study mechanistic aspects of the disease. Unfortunately, nearly all RRV‐infected pups succumb by day of life 14. Thus, in this study we generated an RRV‐TUCH rotavirus reassortant (designated as TR(VP2,VP4)) that when injected into newborn mice causes an obstructive jaundice phenotype with lower mortality rates. Of the mice that survived, 63% developed Ishak stage 3‐5 fibrosis with histopathological signs of inflammation/fibrosis and bile duct obstruction. Conclusions This model of rotavirus‐induced neonatal fibrosis will provide an opportunity to study disease pathogenesis and has potential to be used in preclinical studies with an objective to identify therapeutic targets that may alter the course of BA.</description><subject>Animal models</subject><subject>Animals</subject><subject>Bile</subject><subject>Bile ducts</subject><subject>Biliary atresia</subject><subject>Biliary Atresia - complications</subject><subject>Cell Line</subject><subject>Chlorocebus aethiops</subject><subject>Disease Models, Animal</subject><subject>Fibrosis</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Jaundice</subject><subject>Jaundice, Obstructive - virology</subject><subject>Juveniles</subject><subject>Liver Cirrhosis - etiology</subject><subject>Liver Cirrhosis - virology</subject><subject>Liver diseases</subject><subject>Liver transplantation</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neonates</subject><subject>Original</subject><subject>Phenotypes</subject><subject>Reassortant Viruses</subject><subject>Rotavirus</subject><subject>Therapeutic applications</subject><subject>Viruses</subject><subject>Wound drainage</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc9O3DAQh62qVVmgh75AZamX9pBl_CckuSBtEbBIi4oQXLEcZwJG3nixk6248Q68IU-CtwuIIvU0h_n06TfzI-QrgzED4DvXuBgLqKD4QEYs50UmRA4fyQh4AVnFRLVBNmO8AYBK8vIz2RBMSi44H5HLM9_rpQ1DpGeoY_Sh113_eP9w3DWDwYaeDMF2SE98g476ls7sEgM9tHXw0UZ6qoN2Dl2k02GuO_rLOqvDHZ30AaPV2-RTq13EL89zi1wcHpzvT7PZ76Pj_cksM1KKIsuN5iIva9amK7QpsWZNURnGpZbM8EZKqLBooM2FaQwXIFvJq6LehYqDzLnYIntr72Ko59gY7PqUSy2Cnac0ymur_t109lpd-aUqRJk-wZLgx7Mg-NsBY6_mNhp0Tnfoh6hWTEqYS0jo93fojR9Cl85LVFlCyRmIRP1cUyY9KgZsX8MwUKvWVGpN_W0tsd_epn8lX2pKwM4a-GMd3v3fpKYHp2vlEwVVog4</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Mohanty, Sujit K.</creator><creator>Lobeck, Inna</creator><creator>Donnelly, Bryan</creator><creator>Dupree, Phylicia</creator><creator>Walther, Ashley</creator><creator>Mowery, Sarah</creator><creator>Coots, Abigail</creator><creator>Bondoc, Alexander</creator><creator>Sheridan, Rachel M.</creator><creator>Poling, Holly M.</creator><creator>Temple, Haley</creator><creator>McNeal, Monica</creator><creator>Sestak, Karol</creator><creator>Bansal, Ruchi</creator><creator>Tiao, Greg</creator><general>Wolters Kluwer Health, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8603-2876</orcidid></search><sort><creationdate>202004</creationdate><title>Rotavirus Reassortant–Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia</title><author>Mohanty, Sujit K. ; Lobeck, Inna ; Donnelly, Bryan ; Dupree, Phylicia ; Walther, Ashley ; Mowery, Sarah ; Coots, Abigail ; Bondoc, Alexander ; Sheridan, Rachel M. ; Poling, Holly M. ; Temple, Haley ; McNeal, Monica ; Sestak, Karol ; Bansal, Ruchi ; Tiao, Greg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4437-5ca2358b1f090ac8eb1d79c124a41c2d4409e7d0f53cdc2304f4297b609204523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Bile</topic><topic>Bile ducts</topic><topic>Biliary atresia</topic><topic>Biliary Atresia - complications</topic><topic>Cell Line</topic><topic>Chlorocebus aethiops</topic><topic>Disease Models, Animal</topic><topic>Fibrosis</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Jaundice</topic><topic>Jaundice, Obstructive - virology</topic><topic>Juveniles</topic><topic>Liver Cirrhosis - etiology</topic><topic>Liver Cirrhosis - virology</topic><topic>Liver diseases</topic><topic>Liver transplantation</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neonates</topic><topic>Original</topic><topic>Phenotypes</topic><topic>Reassortant Viruses</topic><topic>Rotavirus</topic><topic>Therapeutic applications</topic><topic>Viruses</topic><topic>Wound drainage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohanty, Sujit K.</creatorcontrib><creatorcontrib>Lobeck, Inna</creatorcontrib><creatorcontrib>Donnelly, Bryan</creatorcontrib><creatorcontrib>Dupree, Phylicia</creatorcontrib><creatorcontrib>Walther, Ashley</creatorcontrib><creatorcontrib>Mowery, Sarah</creatorcontrib><creatorcontrib>Coots, Abigail</creatorcontrib><creatorcontrib>Bondoc, Alexander</creatorcontrib><creatorcontrib>Sheridan, Rachel M.</creatorcontrib><creatorcontrib>Poling, Holly M.</creatorcontrib><creatorcontrib>Temple, Haley</creatorcontrib><creatorcontrib>McNeal, Monica</creatorcontrib><creatorcontrib>Sestak, Karol</creatorcontrib><creatorcontrib>Bansal, Ruchi</creatorcontrib><creatorcontrib>Tiao, Greg</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohanty, Sujit K.</au><au>Lobeck, Inna</au><au>Donnelly, Bryan</au><au>Dupree, Phylicia</au><au>Walther, Ashley</au><au>Mowery, Sarah</au><au>Coots, Abigail</au><au>Bondoc, Alexander</au><au>Sheridan, Rachel M.</au><au>Poling, Holly M.</au><au>Temple, Haley</au><au>McNeal, Monica</au><au>Sestak, Karol</au><au>Bansal, Ruchi</au><au>Tiao, Greg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rotavirus Reassortant–Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>2020-04</date><risdate>2020</risdate><volume>71</volume><issue>4</issue><spage>1316</spage><epage>1330</epage><pages>1316-1330</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><abstract>Background and Aims Biliary atresia (BA) is a devastating neonatal cholangiopathy that progresses to fibrosis and end‐stage liver disease by 2 years of age. Portoenterostomy may reestablish biliary drainage, but, despite drainage, virtually all afflicted patients develop fibrosis and progress to end‐stage liver disease requiring liver transplantation for survival. Approach and Results In the murine model of BA, rhesus rotavirus (RRV) infection of newborn pups results in a cholangiopathy paralleling human BA and has been used to study mechanistic aspects of the disease. Unfortunately, nearly all RRV‐infected pups succumb by day of life 14. Thus, in this study we generated an RRV‐TUCH rotavirus reassortant (designated as TR(VP2,VP4)) that when injected into newborn mice causes an obstructive jaundice phenotype with lower mortality rates. Of the mice that survived, 63% developed Ishak stage 3‐5 fibrosis with histopathological signs of inflammation/fibrosis and bile duct obstruction. Conclusions This model of rotavirus‐induced neonatal fibrosis will provide an opportunity to study disease pathogenesis and has potential to be used in preclinical studies with an objective to identify therapeutic targets that may alter the course of BA.</abstract><cop>United States</cop><pub>Wolters Kluwer Health, Inc</pub><pmid>31442322</pmid><doi>10.1002/hep.30907</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-8603-2876</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-9139
ispartof Hepatology (Baltimore, Md.), 2020-04, Vol.71 (4), p.1316-1330
issn 0270-9139
1527-3350
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7384231
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animal models
Animals
Bile
Bile ducts
Biliary atresia
Biliary Atresia - complications
Cell Line
Chlorocebus aethiops
Disease Models, Animal
Fibrosis
Hepatology
Humans
Jaundice
Jaundice, Obstructive - virology
Juveniles
Liver Cirrhosis - etiology
Liver Cirrhosis - virology
Liver diseases
Liver transplantation
Mice
Mice, Inbred BALB C
Neonates
Original
Phenotypes
Reassortant Viruses
Rotavirus
Therapeutic applications
Viruses
Wound drainage
title Rotavirus Reassortant–Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T23%3A38%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rotavirus%20Reassortant%E2%80%93Induced%20Murine%20Model%20of%20Liver%20Fibrosis%20Parallels%20Human%20Biliary%20Atresia&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Mohanty,%20Sujit%20K.&rft.date=2020-04&rft.volume=71&rft.issue=4&rft.spage=1316&rft.epage=1330&rft.pages=1316-1330&rft.issn=0270-9139&rft.eissn=1527-3350&rft_id=info:doi/10.1002/hep.30907&rft_dat=%3Cproquest_pubme%3E2313358540%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2388082103&rft_id=info:pmid/31442322&rfr_iscdi=true